Rebekka K. Schneider, MD,PhD, was an physician-scientist with international work experience. She was a postdoctoral fellow in Benjamin Ebert’s lab at Harvard Medical School (Boston, USA) and focused on the role of genetic haploinsufficiency in the hematopoietic stem cell biology and targeted therapy of del(5q) myelodysplastic syndrome (Schneider et al. Cancer Cell 2014; Schneider et al. Nature Medicine 2016).
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)